Most of the glutamine transport in lung cancer cells is sodium-dependent, with ASCT2 accounting for about half of this activity, highlighting the prognostic value of ASCT2 in supporting cancer cell metabolism and proliferation [193,194]. The gene discussed is SLC1A5; the disease is lung carcinoma.